Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Leslie, Fecher"'
Autor:
James Larkin, Jeffrey Weber, Victoria Atkinson, Michael Millward, Ivan Marquez-Rodas, Luis de la Cruz-Merino, Helen Gogas, Paolo A Ascierto, Anna Maria Di Giacomo, Veerle de Pril, Vanna Chiarion-Sileni, Stephane Dalle, Leslie Fecher, Ana Arance, Jean-Jacques Grob, Nikhil I Khushalani, Michele Del Vecchio, Mario Mandala, C Lance Cowey, Michael Schenker, Petr Arenberger, Maurice Lobo
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 8 (2021)
Externí odkaz:
https://doaj.org/article/c281f8a682984c818531f79c5352985a
Autor:
Ajjai Alva, Vincent Ma, Leslie Fecher, Kent Griffith, Jessica Waninger, Stephanie Daignault-Newton, Christopher Lao
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/67bd338de87043dd95ede939173065a3
Autor:
Ryan J. Sullivan, Michael B. Atkins, John M. Kirkwood, Sanjiv S. Agarwala, Joseph I. Clark, Marc S. Ernstoff, Leslie Fecher, Thomas F. Gajewski, Brian Gastman, David H. Lawson, Jose Lutzky, David F. McDermott, Kim A. Margolin, Janice M. Mehnert, Anna C. Pavlick, Jon M. Richards, Krista M. Rubin, William Sharfman, Steven Silverstein, Craig L. Slingluff, Vernon K. Sondak, Ahmad A. Tarhini, John A. Thompson, Walter J. Urba, Richard L. White, Eric D. Whitman, F. Stephen Hodi, Howard L. Kaufman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-23 (2018)
Abstract Background Cancer immunotherapy has been firmly established as a standard of care for patients with advanced and metastatic melanoma. Therapeutic outcomes in clinical trials have resulted in the approval of 11 new drugs and/or combination re
Externí odkaz:
https://doaj.org/article/4608673a241f46ca9625955f197bdebe
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-5 (2018)
Abstract Background Immune check point inhibitors (ICIs) have emerged as a new therapeutic paradigm for a variety of malignancies including metastatic melanoma. As the use of ICIs expand, immune-mediated adverse events are becoming a common occurrenc
Externí odkaz:
https://doaj.org/article/1e1f73ceee7245ffbd2c90d76bde1821
Autor:
Michael K. Wong, Melissa Burgess, Sunandana Chandra, Dirk Schadendorf, Ann Silk, Anthony J. Olszanski, Jean-Jacques Grob, Sekwon Jang, Jaspreet Singh Grewal, Karl D. Lewis, Leslie Fecher, Guilherme Rabinowits, Celeste Lebbe, Juan Martin-Liberal, Anna Maria Di Giacomo, Philip Friedlander, Andrew S. Brohl, Brandon Croft, Jesse S. McGreivy, Wayne P. Rothbaum, Glenn J. Hanna, Ciara M. Kelly
Publikováno v:
Journal of Investigative Dermatology. 142:2841
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e573622b76c1bd40ed21a6db815c2db4
https://doi.org/10.1016/j.jid.2022.08.027
https://doi.org/10.1016/j.jid.2022.08.027
Autor:
Michael J. Wagner, Cassandra Hennessy, Alicia Beeghly, Benjamin French, Dimpy P. Shah, Sarah Croessmann, Diana Vilar-Compte, Erika Ruiz-Garcia, Matthew Ingham, Gary K. Schwartz, Corrie A. Painter, Rashmi Chugh, Leslie Fecher, Cathleen Park, Olga Zamulko, Jonathan C. Trent, Vivek Subbiah, Ali Raza Khaki, Lisa Tachiki, Elizabeth S. Nakasone, Elizabeth T. Loggers, Chris Labaki, Renee Maria Saliby, Rana R. McKay, Archana Ajmera, Elizabeth A. Griffiths, Igor Puzanov, William D. Tap, Clara Hwang, Sheela Tejwani, Sachin R. Jhawar, Brandon Hayes-Lattin, Elizabeth Wulff-Burchfield, Anup Kasi, Daniel Y. Reuben, Gayathri Nagaraj, Monika Joshi, Hyma Polimera, Amit A. Kulkarni, Khashayar Esfahani, Daniel H. Kwon, Luca Paoluzzi, Mehmet A. Bilen, Eric B. Durbin, Petros Grivas, Jeremy L. Warner, Elizabeth J. Davis
Publikováno v:
Cancers; Volume 14; Issue 17; Pages: 4334
Background: Patients with sarcoma often require individualized treatment strategies and are likely to receive aggressive immunosuppressive therapies, which may place them at higher risk for severe COVID-19. We aimed to describe demographics, risk fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abf551aa0119067319f6025a1a11a74f
https://doi.org/10.3390/cancers14174334
https://doi.org/10.3390/cancers14174334
Autor:
Maria, Dans, Jean S, Kutner, Rajiv, Agarwal, Justin N, Baker, Jessica R, Bauman, Anna C, Beck, Toby C, Campbell, Elise C, Carey, Amy A, Case, Shalini, Dalal, Danielle J, Doberman, Andrew S, Epstein, Leslie, Fecher, Joshua, Jones, Jennifer, Kapo, Richard T, Lee, Elizabeth T, Loggers, Susan, McCammon, William, Mitchell, Adeboye B, Ogunseitan, Diane G, Portman, Kavitha, Ramchandran, Linda, Sutton, Jennifer, Temel, Melissa L, Teply, Stephanie Y, Terauchi, Jane, Thomas, Anne M, Walling, Finly, Zachariah, Mary Anne, Bergman, Ndiya, Ogba, Mallory, Campbell
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 19(7)
Palliative care has evolved to be an integral part of comprehensive cancer care with the goal of early intervention to improve quality of life and patient outcomes. The NCCN Guidelines for Palliative Care provide recommendations to help the primary o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dadc53d78eea5d87f756c285ca64da3e
https://pubmed.ncbi.nlm.nih.gov/34340208
https://pubmed.ncbi.nlm.nih.gov/34340208
Publikováno v:
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 39
Genetic analysis of melanoma has allowed us to identify a population of patients who have more aggressive disease and harbor the driver mutation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a118e19ef8647985673258569ec107cc
https://pubmed.ncbi.nlm.nih.gov/31099689
https://pubmed.ncbi.nlm.nih.gov/31099689